Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
VBI-S, used in the hypovolemia of septic shock is that it absorbs nitric oxide, a gas produced in excess by the body during hypovolemic shock and that contributes significantly to the drop in blood pressure when volume is lost inside the blood vessels.
Lead Product(s): VBI-S
Therapeutic Area: Cardiology/Vascular Diseases Product Name: VBI-S
Highest Development Status: Phase IIProduct Type: Undisclosed
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 09, 2023
Details:
Vivacelle's VBI-S is likely to be effective in elevating blood pressure to survivable levels and improving oxygenation at early and even late stages of septic shock when current therapy, consisting of fluids and vasopressor medications, have failed.
Lead Product(s): VBI-S
Therapeutic Area: Cardiology/Vascular Diseases Product Name: VBI-S
Highest Development Status: Phase IIProduct Type: Undisclosed
Partner/Sponsor/Collaborator: US Navy
Deal Size: $5.3 million Upfront Cash: Undisclosed
Deal Type: Funding November 24, 2020